ZPHC Retatrutide 60mg kit 5 Vail

Important Regulatory Context: Retatrutide is an investigational compound that has not received marketing approval from the Egyptian Drug Authority (EDA), FDA, EMA, or any other regulatory body. Beast Muscle supplies this product strictly as a research-grade reference material for laboratory use only. It is not intended for human or veterinary consumption.
ZPHC Retatrutide 60mg Kit (5 Vials × 12mg) — A research-grade triple receptor agonist reference material supplied by Beast Muscle Egypt. Each kit contains five lyophilized vials of retatrutide (LY3437943), a 39-amino-acid peptide engineered to target GLP-1, GIP, and glucagon receptors simultaneously. Supplied exclusively for in-vitro laboratory research and analytical applications. Not for human use.

ZPHC Retatrutide 60mg Kit (5 Vials) from Beast Muscle is a multi-vial research kit containing retatrutide, an investigational triple receptor agonist referenced in scientific literature as LY3437943. This compound has drawn significant research interest for its simultaneous activity at three distinct receptor pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.
Each kit contains five individual vials, each containing 12mg of lyophilized retatrutide powder, for a total of 60mg per kit. The lyophilized format is standard for peptide research materials, offering stability during storage and transport when handled according to laboratory protocols.
Research Context: Retatrutide remains an investigational molecule. Phase 3 clinical trials, including the TRIUMPH programme, have been conducted to evaluate its safety and efficacy in obesity and type 2 diabetes under controlled medical supervision. These trials do not constitute regulatory approval, and no regulatory authority worldwide has authorised retatrutide for commercial therapeutic use. Beast Muscle supplies this material exclusively to support laboratory-based research, including receptor binding studies, analytical method development, and peptide characterisation.

What Researchers Should Know:
Receptor targets: GLP-1 (appetite regulation, gastric emptying), GIP (insulin sensitivity, food reward signalling), glucagon (energy expenditure, hepatic lipid metabolism)
Molecular weight: Approximately 4,731 Da (39-mer peptide)
Reported half-life (literature): ~6 days
Supplied as: Lyophilised powder in sealed vials
Kit contents: 5 vials × 12mg retatrutide per vial

Why Beast Muscle Egypt: Beast Muscle operates from Cairo with nationwide delivery across Egypt, offering documented sourcing and cold-chain-compatible shipping for temperature-sensitive research materials. Batch-specific Certificates of Analysis (COA) indicating HPLC purity are available upon request for qualified laboratory purchasers.

DIRECTIONS FOR LABORATORY USE
Storage (pre-reconstitution): Store vials at 2°C–8°C (refrigerated), protected from light. Do not freeze the lyophilised powder.
Reconstitution: Use bacteriostatic water or an appropriate laboratory diluent according to your institution‘s validated protocol. Follow standard peptide handling procedures.
Post-reconstitution stability: Stability is shortened after reconstitution. Aliquot if necessary and minimise freeze-thaw cycles to preserve peptide integrity.
Documentation: Review the batch-specific COA before experimental use. Independently verify all analytical data.
Disposal: Dispose of unused material and reconstituted solutions according to institutional chemical waste procedures.

WARNING
Retatrutide is an investigational compound that has not been approved by the Egyptian Drug Authority (EDA), the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other regulatory authority for therapeutic use. No regulatory body has authorised retatrutide for commercial sale as a medicine.
Serious health risks have been documented with unapproved, non-pharmaceutical-grade retatrutide products obtained outside clinical trial settings. Reported adverse events associated with GLP-1/GIP/glucagon receptor agonist activity include

Note About BEAST MUSCLE

We always strive to update product images on our store according to the versions available to us. There may be some changes in manufacturing, packaging, components, or external appearance from the producing companies. Shipments may carry an alternative shape or a newer version than shown in our store, but this does not reduce the guarantee of quality and originality of the products. We recommend that you read the warnings and instructions for each product before use and do not rely solely on the information provided by BEAST MUSCLE.